Deutsche Biotech Innovativ AG DBI.DU Stock
Deutsche Biotech Innovativ AG Price Chart
Deutsche Biotech Innovativ AG DBI.DU Financial and Trading Overview
| Deutsche Biotech Innovativ AG stock price | 1 EUR |
| Previous Close | 13.5 EUR |
| Open | 12.2 EUR |
| Bid | 3 EUR x 0 |
| Ask | 15.2 EUR x 0 |
| Day's Range | 12.2 - 12.2 EUR |
| 52 Week Range | 0.0005 - 66 EUR |
| Volume | 100 EUR |
| Avg. Volume | 2 EUR |
| Market Cap | 11.56M EUR |
| Beta (5Y Monthly) | 0.167049 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DBI.DU Valuation Measures
| Enterprise Value | 12.61M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 12.5903 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -63.497 |
Trading Information
Deutsche Biotech Innovativ AG Stock Price History
| Beta (5Y Monthly) | 0.167049 |
| 52-Week Change | -95.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 66 EUR |
| 52 Week Low | 0.0005 EUR |
| 50-Day Moving Average | 14.42 EUR |
| 200-Day Moving Average | 25.17 EUR |
DBI.DU Share Statistics
| Avg. Volume (3 month) | 2 EUR |
| Avg. Daily Volume (10-Days) | 10 EUR |
| Shares Outstanding | 947.3K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.50% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2020 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -5.53% |
| Return on Equity (ttm) | -21.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -198544 EUR |
| Net Income Avi to Common (ttm) | -223293 EUR |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 86.78K EUR |
| Total Cash Per Share (mrq) | 0.09 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.015 |
| Book Value Per Share (mrq) | 0.969 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -234000 EUR |
| Levered Free Cash Flow (ttm) | 166.65K EUR |
Profile of Deutsche Biotech Innovativ AG
| Country | Germany |
| State | N/A |
| City | Hennigsdorf |
| Address | Neuendorfstrasse 15a |
| ZIP | 16761 |
| Phone | 49 3302 20 77 824 |
| Website | https://www.dbi-ag.de |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 0 |
Deutsche Biotech Innovativ AG operates as a biotechnology company in Germany. The company develops Adrecizumab, an antibody-based therapy which is in Phase I/II clinical trial for the treatment of septic shock. It also focuses on the development of various drugs for the treatment of solid tumor, organ failure, rosacea, neurodermatitis, pharyngitis, and Alzheimer's diseases. The company was formerly known as Venetus Beteiligungen AG and changed its name to Deutsche Biotech Innovativ AG in August 2014. Deutsche Biotech Innovativ AG was founded in 2009 and is based in Hennigsdorf, Germany.
Q&A For Deutsche Biotech Innovativ AG Stock
What is a current DBI.DU stock price?
Deutsche Biotech Innovativ AG DBI.DU stock price today per share is 1 EUR.
How to purchase Deutsche Biotech Innovativ AG stock?
You can buy DBI.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Deutsche Biotech Innovativ AG?
The stock symbol or ticker of Deutsche Biotech Innovativ AG is DBI.DU.
Which industry does the Deutsche Biotech Innovativ AG company belong to?
The Deutsche Biotech Innovativ AG industry is Biotechnology.
How many shares does Deutsche Biotech Innovativ AG have in circulation?
The max supply of Deutsche Biotech Innovativ AG shares is 947.3K.
What is Deutsche Biotech Innovativ AG Price to Earnings Ratio (PE Ratio)?
Deutsche Biotech Innovativ AG PE Ratio is now.
What was Deutsche Biotech Innovativ AG earnings per share over the trailing 12 months (TTM)?
Deutsche Biotech Innovativ AG EPS is -0.25 EUR over the trailing 12 months.
Which sector does the Deutsche Biotech Innovativ AG company belong to?
The Deutsche Biotech Innovativ AG sector is Healthcare.